Sentences with phrase «treatment study with»

Although relationship dissatisfaction was not reported, another recent treatment study with female depressed IPV victims found that reductions in depressive symptoms (and PTSD symptoms) predicted reduced likelihood of IPV at follow - up (Iverson et al. 2011).

Investigation of therapeutic alliance in a treatment study with substance - abusing women with PTSD.

Not exact matches

An important trigger this year will be the outcome of a study where Darzalex is being tested as first - line treatment in combination with Celgene Corp's Revlimid.

Lilly faced a devastating clinical setback last year with a late - stage failure for its experimental Alzheimer's treatment, the studies for which cost the company hundreds of millions of dollars.

As a result, «we are building on these findings to refine existing treatments to boost feelings of being safe and supported in order to improve coping with traumatic memories,» said Dr. Anke Karl, one of the authors, wrote of the study.

Private hospitals are typically the best equipped, with state - of - the art technology and doctors that have studied in the world's best medical universities — many of them speak English and are well acquainted with the newest diagnostic and treatment procedures... some of which may not yet be available in the U.S., for example.

In a late - stage study, Aimmune, a biotech immunotherapy allergy treatment taken via pill, found that of the roughly 500 kids with peanut allergies between the ages of 4 - 17 who were part of the trial, 67 % of those who received the treatment were able to tolerate 600 milligrams of peanut protein (about two to four peanuts) after about a year of treatment, while only 4 % of those who got the placebo could tolerate that dose of peanut protein.

While the research was aimed at eventually developing treatments for those suffering from PTSD, the study authors said these initial findings were also useful for those of us who just have to deal with normal negativity like marital spats and nasty work disagreements.

The company is chasing an at least $ 80 million IPO to help fund the phase 3 studies that would be necessary for the Food and Drug Administration (FDA) to clear the treatment (the company has made modifications to the experimental, once - a-day pill that fights brain plaque buildup associated with Alzheimer's).

Pagan said that a larger, more comprehensive study must be done before determining the drug's true impact, but if the drug's effectiveness is confirmed in such tests, nilotinib could become the first treatment to impede the killing of brain cells that's consistent with Parkinson's, according to NPR.

«More than twice the number of patients [were] still living at the end of the study after receiving IMAB362 plus chemotherapy compared to chemotherapy alone,» according to Ganymed CEO Özlem Türeci, with patients showing the highest level of that protein biomarker responding best to the treatment.

Through week 48, Biktarvy was found to be statistically non-inferior to ABC / DTG / 3TC with a numerically lower incidence of mild or moderate study drug - related adverse events and no treatment - emergent resistance;

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Chicago, GenomeWeb — A new study by researchers from Memorial Sloan Kettering Cancer Center has demonstrated the predictive power of an AR - V7 protein expression test using Epic Sciences» non-EPCAM-based circulating tumor cell detection platform, which could help guide treatment decisions for men with metastatic castration - resistant prostate cancer.

The biotech specialist said that its updated phase 2 data in a study of its poziotinib candidate treatment for non-small cell lung cancer resulted in a preliminary confirmed objective response rate and potential progression - free survival benefit in patients with the EGFR Exon 20 Mutant form of the disease.

Patisiran was being evaluated in a late - stage study against a placebo for the treatment of patients with hereditary ATTR (hATTR) amyloidosis with polyneuropathy.

During a study that led to Dupixent's approval, injections every other week, combined with topical steroid creams helped 69 % of patients achieve 75 % clear skin, after 16 weeks of treatment.

What's missing, in other words, is children with something actually to worry about — worries less amenable to the «low - cost treatment» proposed by NYU's Child Study Center.

Many of the things he said, the way he said them... he did not study the same as I did for certain, and anyone who believes they converse with god, should not be involved with anyone elses treatment.

There is knowledge to be gained by such studies, of course, but it hardly makes for the sort of case embryo - research advocates were advancing just a few years ago — with its miracle cures and treatments for the untreatable.

The author opines, rightly, how useful it would be to construct a synthesis of mental health treatments and authentic Catholic spirituality, fleshing this out with some brief case studies.

Whereas Vermes first stakes out a topic and then works his way to particulars by adducing historical considerations, Crossan isolates a cluster of sayings on a topic, considers only the earliest and doubly attested, and then compares the treatment of the theme with Greek as well as Jewish materials in order to develop an interpretation based on anthropological studies of Mediterranean peasants.

It should be studied along with the treatments of this theme by Machiavelli and Rousseau, where there is discussion of such figures as Moses and Romulus.

The study discovered that stage 3 and 4 breast cancer women who supplemented their diet with virgin coconut oil during breast cancer treatment improved fatigue, dyspnea, sleep difficulties, and loss of appetite compared to the control group.

Capsaicin, the substance that gives chiles their fire, is being studied as an effective treatment for sensory nerve fiber disorders, including pain associated with arthritis,

Studies confirm that graduates of the program wait longer to engage in sex; have fewer partners; and are more willing to talk about HIV with peers and relatives, take an HIV test and stay on treatment if they test positive.

• Almost exactly the same treatment / quit ratio was found in a Hong Kong study, with — again — almost double the quit rate in the intervention group.

WebMD reports males undergoing infertility treatments with their partners were studied and showed an 11 percent decrease in fertility every year.

reports males undergoing infertility treatments with their partners were studied and showed an 11 percent decrease in fertility every year.

The study focused on a progesterone gel treatment that was found to be effective in reducing early births of singletons but did not have the same effect with multiples.

As with any new treatment, there are few studies reporting on the effectiveness of PRP, and even those that have been published are debated by experts, leading the American Academy of Orthopaedic Surgeons to the «hottest topic in orthopedics.»

As a result, Dr. Meehan argues that «the term mild traumatic brain injury should not be used interchangeably with concussion,» as suggested by the authors of a 2010 Canadian study, 2 which found that how a brain injury was labeled made a difference when it came to treatment, and suggested that, to encourage full reporting of head injuries in sports and to allow adequate management and recovery time, MTBI be used in its place.

scientific study has learneed that the benzodiazepine drug treatments, the actual Valiums along with Xanaxes, perform how they do by interesting any natural chemical called «gamma - aminobutyric acid, or even Gamma aminobutyric acid, therefore selling a relaxing impact in only exactly the same as the highly habit forming opioids.

After residency, Dr. Chandra spent 5 years studying with, and working with, Dr. William Lee Cowden, MD a leading expert in the treatment of chronic Lyme disease and other complex medical conditions.

This board would then spend 20 billion dollars over the next decade marketing the health benefits of real food with tv and magazine adds, and a massive PR campaign to report on studies that link real food consumption to wellness, vitality and disease treatment.

Read about the phase 1 study at Duke University that assessed 25 children with autism spectrum disorder who received treatment with their own cord blood.

According to a systematic review, a small body of research suggests that treatment may be associated with mother - reported improvements in breastfeeding, but the studies are small, short - term, and rely on inconsistent methodology.

According to one study, identical twins made up 0.95 percent of the pregnancies conceived with treatment.

Studies show a higher rate of identical twins (up to 20 times with IVF) in women having these treatments than occur naturally.

However, whether varicocele treatment improves pregnancy success rates in all cases is a matter of debate, with some studies showing improved conception rates and others not.

I hope that findings from this study will eventually help develop better psychotherapy treatments for women with infertility.

In a previous study where we explored women's preferences for aspects of intrapartum care regarding planned place of birth we reported that women with a preference for a hospital birth — both midwife - led and obstetrician - led — found the possibility of pain relief treatment much more important compared to women with a preference for a home birth [18].

For the purposes of this economic evaluation, the forms were initially used in a related study funded by the National Institute of Health Research (NIHR) research for patient benefit programme «assessing the impact of a new birth centre on choice and outcome of maternity care in an inner city area,» which will be reported in full elsewhere, comparing the costs of care in a free standing midwifery unit with care in an obstetric unit in the same trust.16 The data collected included details of staffing levels, treatments, surgeries, diagnostic imaging tests, scans, drugs, and other resource inputs associated with each stage of the pathway through intrapartum and after birth care.

less than or equal to lamivudine Acquired Immune Deficiency Syndrome Antiretroviral therapy, usually means 1 - 2 drugs, used in early studies Antiretroviral zidovudine (also known as ZDV) Breastfeeding Baby Friendly Hospital Initiative Breastfeeding and HIV International Transmission Study Combined antiretroviral therapy Centers for Disease Control and Prevention Deoxyribonucleic Acid Exclusive Breastfeeding Enzyme Linked Immunosorbent Assay Food and Agrigulture Organization Fixed dose combination ART, e.g., lamividine, stavudine, and nevirapine Highly Active Antiretroviral Therapy, 3 or more drugs for more effective treatment used in later studies Human Immunodeficiency virus International Atomic Energy Agency Infant feeding Infant and young child feeding Lopinavir cubic millimetre Mother - to - Child Transmission of HIV Non-governmental organization Nevirapine Polymerase Chain Reaction People Living with HIV Prevention of Mother - to - Child Transmission Replacement Feeding Ritonavir Ribonucleic acid, one of the three major macromolecules (along with DNA and proteins) that are essential for all known forms of life single dose NVP United Nations Agencies Joint United Nations Programme on HIV / AIDS United Nations Population Fund United Nations Commissioner for Refugees United Nations Children's Fund U.S. Agency for International Development World Alliance for Breastfeeding Action United Nations World Food Programme World Health Assembly WHO 2010 Guidelines on HIV and infant feeding World Health Organization Zidovudine (same drug as AZT)

Although a few reports of late onset GBS in infants whose mothers also expressed GBS in their breastmilk are described in the literature, with the standard medical treatment of breastmilk as just some infectious bodily fluid, no studies are to be found specifically comparing overall GBS infections in infants to presence or absence of exclusive human milk feeding.

Comparisons possible were: 3 studies with treatment arms differing only in the approach (group, individual or self - administered), 2 studies differing only in number of sessions and 5 studies differing only in adjunctive treatment.

The objective of the current study was to systematically review randomised controlled trials of parenting programmes for the treatment of children with conduct problems.

While there is some evidence to suggest that helmeted children recognize that they are somehow different, a 2008 study on the quality of life of children who had undergone helmet therapy discovered that 96 % of patients and their families were satisfied with treatment results.

In future updates, if more eligible studies are included, we will explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis.

The difference in the average treatment effect in overall fetal loss and neonatal death across included trials between women allocated to midwife - led continuity models of care and women allocated to other models has an average risk ratio (RR) of 0.84, with 95 % confidence interval (CI) 0.71 to 0.99 (participants = 17561; studies = 13).